Mechanism of action of the oxazolidinone antibacterial agents
about
Population pharmacokinetics and pharmacodynamics of linezolid-induced thrombocytopenia in hospitalized patients.Emergence of linezolid resistance in a clinical Staphylococcus capitis isolate from Jiangsu Province of China in 2012.Mechanisms of linezolid resistance among coagulase-negative staphylococci determined by whole-genome sequencing.Resistance to linezolid: characterization of mutations in rRNA and comparison of their occurrences in vancomycin-resistant enterococci.Cross-linking in the living cell locates the site of action of oxazolidinone antibiotics.Exploiting current understanding of antibiotic action for discovery of new drugs.Genetic changes that correlate with reduced susceptibility to daptomycin in Staphylococcus aureus.Nonclinical and pharmacokinetic assessments to evaluate the potential of tedizolid and linezolid to affect mitochondrial functionLack of neuropathological changes in rats administered tedizolid phosphate for nine months.Linezolid: implications for neurosurgical infections.LEADER Program results for 2009: an activity and spectrum analysis of linezolid using 6,414 clinical isolates from 56 medical centers in the United States.Clonal dissemination of linezolid-resistant Staphylococcus capitis with G2603T mutation in domain V of the 23S rRNA and the cfr gene at a tertiary care hospital in China.In vitro activities of the novel oxazolidinones DA-7867 and DA-7157 against rapidly and slowly growing mycobacteria.Systematic review and meta-analysis of the efficacy and safety of therapy with linezolid containing regimens in the treatment of multidrug-resistant and extensively drug-resistant tuberculosis.First linezolid-resistant clinical isolates of Mycobacterium tuberculosisMutations in the DNA mismatch repair proteins MutS and MutL of oxazolidinone-resistant or -susceptible Enterococcus faecium.Clinical update on linezolid in the treatment of Gram-positive bacterial infections.Multidrug Intrinsic Resistance Factors in Staphylococcus aureus Identified by Profiling Fitness within High-Diversity Transposon Libraries.Emerging drugs for bacterial urinary tract infections.The ribosomal peptidyl transferase center: structure, function, evolution, inhibition.Clinical and microbiological aspects of linezolid resistance mediated by the cfr gene encoding a 23S rRNA methyltransferase.Linezolid Surveillance Results for the United States (LEADER Surveillance Program 2014).Linezolid: effectiveness and safety for approved and off-label indications.Early and extended early bactericidal activity of linezolid in pulmonary tuberculosisProdrugs for the treatment of neglected diseases.Emergence and management of drug-resistant enterococcal infections.Tuberculosis drugs: new candidates and how to find more.The oxazolidinones: past, present, and future.New antibacterial agents: patent applications published in 2011.History and evolution of antibiotic resistance in coagulase-negative staphylococci: Susceptibility profiles of new anti-staphylococcal agents.Drug-drug interactions and safety of linezolid, tedizolid, and other oxazolidinones.Delayed development of linezolid resistance in Staphylococcus aureus following exposure to low levels of antimicrobial agentsOxazolidinone antibiotics target the P site on Escherichia coli ribosomes.Development of methionyl-tRNA synthetase inhibitors as antibiotics for Gram-positive bacterial infections.In vitro activity of TR-700, the antibacterial moiety of the prodrug TR-701, against linezolid-resistant strains.In vitro activities of DA-7157 and DA-7218 against Mycobacterium tuberculosis and Nocardia brasiliensis.An evolved oxazolidinone with selective potency against Mycobacterium tuberculosis and gram positive bacteria.Comparative in vitro activities of torezolid (DA-7157) against clinical isolates of aerobic and anaerobic bacteria in South Korea.Acquisition of a natural resistance gene renders a clinical strain of methicillin-resistant Staphylococcus aureus resistant to the synthetic antibiotic linezolid.Oxazolidinones: new players in the battle against multi-resistant Gram-positive bacteria.
P2860
Q33439246-11A3E5DB-ADA6-416A-844C-90102504CB9DQ33586058-F509DACE-D1CB-4C4A-B71A-ABFD1D813167Q33648052-2823FF17-C96B-4257-8633-F6AE43F3ECB0Q33982606-0AE1530E-ED98-439A-BD85-CDDBA8D01739Q34189984-E5D5FCEF-8D94-43B8-BD85-2D5B35BADCFBQ34631418-FDEC0D0F-9613-4C96-930B-7363E179E09EQ34680589-80E1545D-0A31-4F8D-B102-97D84A3C3E50Q34922189-1B18A19A-97F1-468C-AA9E-A567AF35D3B7Q34922770-D12DD231-EB80-4A21-B900-A3B01B7C26D8Q35058749-FE572924-C852-4BD6-B0CC-F0AD0AC8BFD5Q35139437-D7A0380D-7368-4717-84EC-3D150274D638Q35156327-7789FB69-5661-40E6-A761-6AD100CD650BQ35215417-7EB363E6-19AE-4341-8920-3BF80D861E6DQ35568367-8E053E67-5E13-4C91-8920-01244FC1687FQ35758951-8EA8E6DA-88FD-4DBB-8972-BCAFE2C4E43BQ36048384-03818326-56E0-4E18-BE86-ECACD68047F1Q36083208-D1FA2CF2-ECBE-4B75-9064-CEF216AF696FQ36105516-A93D1906-3C22-4FF1-994A-824410D9FE26Q36150606-08994664-443C-4D08-8B79-097C4ED2B3FEQ36300790-2D4EE233-0339-4DCE-9FC8-1CF9783210C5Q36497918-F1D3C0FD-F671-445B-BE0A-1BB79BD61D4BQ36730155-DC16DE48-4AAB-4D6A-BC69-0470D31F1ABBQ36967288-351B75C5-5EAE-453E-9702-09F52FE2A0FCQ36986669-A2DED21F-3FC4-4813-90F6-59F3E600EDB2Q37157236-BC458820-3BFB-4C6D-9D7E-4B2FCC7DFC94Q37291346-1D94AE81-FE99-4859-87F7-C72CD9CE5D50Q37894691-BABC64D3-50C3-49DC-A41D-8BE0E5C7FACCQ37970719-7633AA99-D5C9-4BF4-9DA9-957B4A4CB961Q38172657-D0C63C09-0BF8-4A97-A932-5A404B15B908Q38536137-198C648E-2D68-4592-894C-78AEDFDB6915Q38604890-EEDB3140-3339-4452-AB5C-2BBD45CFF5B8Q38898545-F3959643-E1E9-4A08-9EEB-09078F510A56Q39651378-DFF902A0-FF02-489D-BFA3-A4F2B847F8EDQ40077119-0F340D33-9981-444F-9337-1D1F87481BE4Q41389487-784A6CCD-2F10-47C0-A963-1DD821C1C316Q41770076-08B853F3-D22B-40CF-9CC3-DD40EE06080AQ41864236-0023829C-6349-47B6-8B27-C3669F8C5919Q42111215-22C24FBB-5B79-4CD6-B6BE-3A86E5F95E2EQ43092355-9BAC6773-4804-4755-AD37-B4C1BB269B6CQ46576587-45AB4901-C57A-49F5-BD9E-657279EBAB04
P2860
Mechanism of action of the oxazolidinone antibacterial agents
description
1999 nî lūn-bûn
@nan
1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Mechanism of action of the oxazolidinone antibacterial agents
@ast
Mechanism of action of the oxazolidinone antibacterial agents
@en
Mechanism of action of the oxazolidinone antibacterial agents
@nl
type
label
Mechanism of action of the oxazolidinone antibacterial agents
@ast
Mechanism of action of the oxazolidinone antibacterial agents
@en
Mechanism of action of the oxazolidinone antibacterial agents
@nl
prefLabel
Mechanism of action of the oxazolidinone antibacterial agents
@ast
Mechanism of action of the oxazolidinone antibacterial agents
@en
Mechanism of action of the oxazolidinone antibacterial agents
@nl
P2860
P3181
P1476
Mechanism of action of the oxazolidinone antibacterial agents
@en
P2093
D Shinabarger
P2860
P304
P3181
P356
10.1517/13543784.8.8.1195
P407
P577
1999-08-01T00:00:00Z